(Q47411366)

15 January 2018

title

Very small size proteoliposomes derived from Neisseria meningitidis: an effective adjuvant for Th1 induction and dendritic cell activation (English)

1 reference

15 January 2018

main subject

Neisseria meningitidis

1 reference

1 reference

Circe Mesa

1

1 reference

15 January 2018

Joel De León

series ordinal

2

1 reference

15 January 2018

Kevin Rigley

series ordinal

3

1 reference

15 January 2018

Luis E Fernández

series ordinal

4

1 reference

15 January 2018

language of work or name

English

0 references

publication date

1 August 2004

1 reference

15 January 2018

published in

Vaccine

1 reference

15 January 2018

volume

22

1 reference

15 January 2018

issue

23-24

1 reference

15 January 2018

page(s)

3045-3052

1 reference

15 January 2018

Tolerance, danger, and the extended family

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.010

OmpA targets dendritic cells, induces their maturation and delivers antigen into the MHC class I presentation pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.010

CpG DNA: a potent signal for growth, activation, and maturation of human dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.010

Interaction of Neisseria meningitidis with human dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.010

Dendritic cell activation and cytokine production induced by group B Neisseria meningitidis: interleukin-12 production depends on lipopolysaccharide expression in intact bacteria.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.010

Liposomal meningococcal B vaccination: role of dendritic cell targeting in the development of a protective immune response.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.010

Enhancement of the immune response to poorly immunogenic gangliosides after incorporation into very small size proteoliposomes (VSSP).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.010

A purified GM3 ganglioside conjugated vaccine induces specific, adjuvant-dependent and non-transient antitumour activity against B16 mouse melanoma in vitro and in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.010

Immunotherapy of advanced breast cancer with a heterophilic ganglioside (NeuGcGM3) cancer vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.010

Montanide ISA 720 and 51: a new generation of water in oil emulsions as adjuvants for human vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.010

Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.010

Dendritic cells: a link between innate and adaptive immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.010

Toll-like receptors and T-helper-1/T-helper-2 responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.010

A natural immunological adjuvant enhances T cell clonal expansion through a CD28-dependent, interleukin (IL)-2-independent mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.010

Safety and immunogenicity of a hepatitis B vaccine formulated with a novel adjuvant system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.010

Distinct dendritic cell subsets differentially regulate the class of immune response in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.010

CD8alpha+ and CD8alpha- subclasses of dendritic cells direct the development of distinct T helper cells in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.010

Danger signals: SOS to the immune system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.010

A filarial nematode-secreted product signals dendritic cells to acquire a phenotype that drives development of Th2 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.010

Distinct CpG DNA and polyinosinic-polycytidylic acid double-stranded RNA, respectively, stimulate CD11c- type 2 dendritic cell precursors and CD11c+ dendritic cells to produce type I IFN

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.010

The interleukin-12/interleukin-12-receptor system: role in normal and pathologic immune responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.010

Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.010

Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 Gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.010

The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.010

Characterization of a nontoxic monophosphoryl lipid A.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.010

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2004.02.010

1 reference

15 January 2018

1 reference

15 January 2018